Thomas Najarian
Publications by Year
Research Areas
Pharmacology and Obesity Treatment, Growth Hormone and Insulin-like Growth Factors, Thyroid Disorders and Treatments, Diet and metabolism studies, Eating Disorders and Behaviors
Most-Cited Works
- → Controlled‐Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)(2011)707 cited
- → Prevalence and Determinants of Valvulopathy in Patients Treated With Dexfenfluramine(1999)83 cited
- → MORTALITY FROM LEUKÆMIA AND CANCER IN SHIPYARD NUCLEAR WORKERS(1978)71 cited
- → A randomized, placebo‐controlled crossover trial of phentermine‐topiramate ER in patients with binge‐eating disorder and bulimia nervosa(2019)65 cited
- → Study protocol and rationale for a randomized double-blinded crossover trial of phentermine-topiramate ER versus placebo to treat binge eating disorder and bulimia nervosa(2017)15 cited
- → Nifedipine and Nimodipine Competitively Inhibit Uridine Kinase and Orotidine-Phosphate Decarboxylase: Theoretical Relevance to Poor Outcome in Stroke(2000)9 cited
- → Hematologic Effect of cis-Platinum-Bleomycin Therapy(1981)7 cited
- → Maladaptive Hypothyroidism, or The Famine Response, After Bariatric Surgery: TSH not the Gold Standard For Detection(2016)3 cited
- TSH is Not the Answer: Rationale for a New Paradigm to Evaluate and Treat Hypothyroidism, Particularly Associated with Weight Loss(2011)
- → Do early indicators of euthyroid sick syndrome predict later post-bariatric weight loss? Exploring a novel hypothesis(2024)2 cited